This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543

June 2023

Wales Neurodevelopmental Disorders Webinar

This event took place on Wednesday 15 June 2022
Watch on-demand our guest speakers Dr Antonio Munoz-Solomando, Dr Sunil Pulapaka, Dr Usha Roy and Emma Brierley. The speakers' combined expertise explore a number of topics including the effective management of sleep difficulties in young people with neurodevelopmental disorders and the effective management and treatment of ADHD patients.
Your certificate will be available in your account once you have watched the on-demand video.

Agenda

15:00
Welcome and Introduction, Dr Antonio Munoz-Solomando
15:05
Sleep Difficulties in Children with Neurodevelopmental Disorders and Management Options, Dr Sunil Pulapaka
15:50
ADHD with Comorbidities - Diagnosis and Management of Young People, Dr Usha Roy
16:35
Melatonin Prescribing and Implementation of a Shared Care Pathway, Emma Brierley
17:00
Question and Answer Discussion
17:25
Meeting Close
Dr Antonio Munoz-Solomando
Dr Antonio Munoz-Solomando
Consultant Child and Adolescent Psychiatrist Clinical Lead CTM CAMHS, Cwm Taf Morgannwg Health Board

Dr Antonio Munoz-Solomando is originally from Majorca but has lived in Wales for a long time. He went to medical school in Granada, Spain and trained as a Child and Adolescent Psychiatrist in South Wales. He has been a Consultant for the Community Intensive Team in Cwm Taf Morgannwg UHB since 2006 and Clinical Lead for CAMHS for more than 10 years.

He is a Fellow of the Royal College of Psychiatrists with a background on research having published on transition services and neurodevelopmental disorders, but his time is currently spent in the strategic development of the service.

Dr Sunil Pulapaka
Dr Sunil Pulapaka
Consultant Child and Adolescent Psychiatrist and Clinical Lead Neurodevelopment Service PAEDS CTM, Cwm Taf Morgannwg Health Board

Dr Sunil Pulapaka is an experienced Consultant Child & Adolescent Psychiatrist with 16 years’ experience in CAMHS. He has has been a Member of the Royal College of Psychiatrists since 2005, completing his certificate of training in Child and Adolescent Psychiatry from Greater Glasgow and Clyde & Lanarkshire NHS Trust.

Working within child and adolescent services he has gained considerable experience in the identification, assessment, and treatment of numerous disorders, including anxiety, depression, OCD, eating disorders and early onset psychosis, as well as attachment and post-traumatic stress disorders and foetal alcohol syndrome. Dr Pulapaka is clinical lead for the neurodevelopmental service, and is responsible for the assessment, diagnosis, and treatment of neurodevelopmental conditions (including ADHD, Tic Disorders, and ASD). He is trained in 3DI, DISCO and ADOS tools for assessment of ASD.

Dr Pulapaka is a regional advisor for RCPsych CAP faculty, Wales, CASC Examiner for Royal College of Psychiatry, PLAB examiner for GMC and recruitment lead and educational supervisor for Health Education and Improvement Wales.

Dr Usha Roy
Dr Usha Roy
Associate Specialist Community Paediatrician Birmingham Community Healthcare NHS Foundation Trust

Dr Usha Roy has worked in Birmingham Community Healthcare NHS Foundation Trust as an associate specialist for 20 years. She leads on ADHD, an area of special interest to her, conducting weekly new and follow up clinics, working closely with Birmingham’s ADHD specialist nurse service.

Emma Brierley
Emma Brierley
Lead Specialist Pharmacist Neurodevelopment Service PAEDS CTM, Cwm Taf Morgannwg Health Board

Emma Brierley is the Lead Pharmacist for the Neurodevelopmental Service in Cwm Taf Morgannwg University Health Board. Emma joined the NHS in 2015 where she worked in the Child and Adolescent Mental Health Service (CAMHS). This is where her passion for working with and supporting young people with neurodevelopmental disorders began.

Emma joined the Neurodevelopmental Service in 2019, which enabled her to focus on assessing, diagnosing, and supporting young people with ADHD and Autistic Spectrum Disorder. Emma’s roles in CAMHS and the Neurodevelopmental Service have been pioneering and she is keen to support other pharmacists and colleagues within this field.

What will the webinar cover?

Key learning objectives

  • To explore the effective management of sleep difficulties in young people with neurodevelopmental disorders, including pharmacological treatments
  • To discuss the effective management and treatment of ADHD patients and common comorbid conditions
  • To provide strategies and treatment options, exploring both behavioural and pharmaceutical interventions
  • To examine the implementation of local shared care protocols and sleep pathways